Takeda Pharmaceutical (TAK) reported fiscal Q4 core earnings Thursday of 49 Japanese yen ($0.34) per share, down from 72 yen a year earlier.
Four analysts polled by FactSet expected 55.38 yen.
Revenue for the quarter ended March 31 was 1.053 trillion yen, up from 1.051 trillion yen a year earlier.
Analysts surveyed by FactSet expected 1.073 trillion yen.
The company expects core EPS for its next fiscal year to be 485 yen. Analysts surveyed by FactSet expect 508.33 yen.
The company expects full-year revenue of 4.530 trillion yen. Analysts polled by FactSet expects 4.602 trillion yen.
Takeda shares were down 3% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。